Document:

<PAGE>
                                                                     EXHIBIT 4.1

                            CERTIFICATE OF AMENDMENT
                                       OF
                           FOURTH AMENDED AND RESTATED
                          CERTIFICATE OF INCORPORATION
                                       OF
                           WRIGHT MEDICAL GROUP, INC.

         WRIGHT MEDICAL GROUP, INC., a corporation duly organized and existing
under the General Corporation Law of the State of Delaware (the "Corporation"),
does hereby certify that:

         I. The amendment to the Fourth Amended and Restated Certificate of
Incorporation of the Corporation (the "Certificate of Incorporation") set forth
below was duly adopted in accordance with the provisions of Section 242 of the
General Corporation Law of the State of Delaware.

         II. Article IV of the Certificate of Incorporation is amended to read
in its entirety as follows:

                                   ARTICLE IV

              The total authorized capital stock of the Corporation shall be
       105,000,000 shares consisting of 100,000,000 shares of Common Stock, $.01
       par value per share ("Common Stock"), and 5,000,000 shares of Preferred
       Stock, $.01 par value per share ("Preferred Stock").

              The Preferred Stock may be issued from time to time in one or more
       series, each of which series shall have such distinctive designation or
       title and such number of shares as shall be fixed by the Board of
       Directors prior to the issuance of any shares thereof. Each such series
       of Preferred Stock shall have such voting powers, full or limited, or no
       voting powers, and such preferences and relative, participating, optional
       or other special rights and such qualifications, limitations or
       restrictions thereof, as shall be stated and expressed in the resolution
       or resolutions providing for the issue of such series of Preferred Stock
       as may be adopted from time to time by the Board of Directors prior to
       the issuance of any shares thereof pursuant to the authority hereby
       expressly vested in it. The Board of Directors is further authorized to
       increase or decrease (but not below the number of shares outstanding) the
       number of shares of any series of Preferred Stock subsequent to the
       issuance of shares of that series. In case the number of shares of any
       series shall be so decreased, the shares constituting such decrease shall
       resume the status of which they had prior to the adoption of the
       resolution originally fixing the number of shares of such series. Except
       as provided in the resolution or resolutions of the Board of Directors
       creating any series of Preferred Stock or as otherwise provided herein,
       the shares of Common Stock shall have the exclusive right to vote for the
       election and removal of directors and for all other purposes.

       IN WITNESS WHEREOF, the Corporation has caused this Certificate to be
executed by F. Barry Bays, its authorized officer, on May 13, 2004.

                                         /s/ F. Barry Bays
                                         -------------------------------------
                                         F. Barry Bays
                                         President and Chief Executive Officer<PAGE>

                                                                    EXHIBIT 4.6

                        EXECUTIVE STOCK OPTION AGREEMENT

         THIS AGREEMENT, made as of _____________ (the "Effective Date"), by
and between Wright Medical Group, Inc., a Delaware corporation formerly known
as Wright Acquisition Holdings, Inc. (the "Company"), and _______________ (the
"Participant").

                              W I T N E S S E T H:
                              - - - - - - - - - -

         WHEREAS, the Company desires to afford the Participant the opportunity
to acquire ownership of the Company's common stock, par value $.01 per share
("Common Stock"), so that he may have a direct proprietary interest in the
Company's success.

         NOW, THEREFORE, in consideration of the covenants and agreements
herein contained, the parties hereby agree as follows:

         1.       Grant of Options. Subject to the terms and conditions set
forth herein and in the Company's Third Amended and Restated 1999 Equity
Incentive Plan, a copy of which is attached hereto as Exhibit A (the "Plan"),
on the Effective Date the Company does hereby grant to the Participant, during
the period commencing on the Effective Date and ending on the 10th anniversary
of the Effective Date (the "Expiration Date"), the right and option (the right
to purchase any one share under this Agreement being an "Option") to purchase
from the Company ________ shares of Common Stock. The Option to purchase such
Common Stock shall have an exercise price of $_________ per share. Each of the
Options granted pursuant to this Agreement shall, to the fullest extent
permissible under Section 422 of the Code, constitute Incentive Stock Options
under the Plan.

         2.       Limitations on Exercise of Options.

                  (a)      Subject to the terms and conditions set forth herein
and in the Plan, the Options shall vest and become exercisable, on a cumulative
basis, with respect to 25% of the shares of Common Stock on the first
anniversary of the Effective Date and on each succeeding anniversary thereafter
so long as the Participant is employed by the Company; provided, however, that
upon the occurrence of a Change of Control (as defined below), all of the then
unvested Options shall automatically vest and be fully exercisable and shall
remain so exercisable in accordance with the terms of this Agreement. The
Committee or the Board may accelerate the vesting and exercisability of any or
all of the then unvested Options at any time.

                  (b)      For purposes of this Agreement, a "Change of
Control" shall mean:

                           (i)      The acquisition by any individual, entity
or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities
Exchange Act of 1934, as amended (the "Exchange Act")) (a "Person") of
beneficial ownership (within the meaning of Rule 13d-3 promulgated under the
Exchange Act) of 50% or more (on a fully diluted basis) of either (A) the then
outstanding shares of common stock of the Company, taking into account as
outstanding for this purpose such common stock issuable upon the exercise of
options or warrants, the conversion of convertible stock or debt, and the
exercise of any similar right to acquire such

<PAGE>

common stock (the "Outstanding Company Common Stock") or (B) the combined
voting power of the then outstanding voting securities of the Company entitled
to vote generally in the election of directors (the "Outstanding Company Voting
Securities"); provided, however, that for purposes of this subsection (i), the
following acquisitions shall not constitute a Change of Control: (w) any
acquisition pursuant to an initial public offering of shares of common stock of
the Company pursuant to a registration statement declared effective under the
Securities Act, (x) any acquisition by the Company or any "affiliate" of the
Company, within the meaning of 17 C.F.R. Section 230.405 (an "Affiliate"), (y)
any acquisition by any employee benefit plan (or related trust) sponsored or
maintained by the Company or any Affiliate, (z) any acquisition by any
corporation or business entity pursuant to a transaction which complies with
clauses (A), (B), (C) and (D) of subsection (ii) of this Section 2(b) (persons
and entities described in clauses (w), (x), (y) and (z) being referred to
herein as "Permitted Holders"); or

                           (ii)     The consummation of a reorganization,
merger or consolidation, or sale or other disposition of all or substantially
all of the assets of the Company (a "Business Combination"), in each case,
unless, following such Business Combination, (A) all or substantially all of
the individuals and entities who were the beneficial owners, respectively, of
the Outstanding Company Common Stock and Outstanding Company Voting Securities
immediately prior to such Business Combination beneficially own, directly or
indirectly, more than 60% of, respectively, the then outstanding shares of
common stock and the combined voting power of the then outstanding voting
securities entitled to vote generally in the election of directors, as the case
may be, of the corporation resulting from such Business Combination (including,
without limitation, a corporation which as a result of such transaction owns
the Company or all or substantially all of the Company's assets either directly
or through one or more subsidiaries) in substantially the same proportions as
their ownership, immediately prior to such Business Combination, of the
Outstanding Company Common Stock and Outstanding Company Voting Securities, as
the case may be, (B) no Person (excluding any Permitted Holder) beneficially
owns, directly or indirectly, 50% or more (on a fully diluted basis) of,
respectively, the then outstanding shares of common stock of the corporation
resulting from such Business Combination, taking into account as outstanding
for this purpose such common stock issuable upon the exercise of options or
warrants, the conversion of convertible stock or debt, and the exercise of any
similar right to acquire such common stock, or the combined voting power of the
then outstanding voting securities of such corporation except to the extent
that such ownership existed prior to the Business Combination, (C) at least a
majority of the members of the board of directors of the corporation resulting
from such Business Combination were members of the incumbent Board at the time
of the execution of the initial agreement providing for such Business
Combination, and (D) immediately following the Business Combination, the
Participant is the (Job Title) of, as the case may be, (1) the ultimate
parent entity of (x) the entity that survives the merger of the Company with
another entity in the Business Combination, (y) the entity that results from the
consolidation of the Company with another entity in the Business Combination, or
(z) the entity to which the Company's assets are sold or otherwise transferred
in the Business Combination, or (2) if there is no such parent entity, the
entity described in the immediately preceding clause (x), (y) or (z); or

                           (iii)    The approval by the shareholders of the
Company of a complete liquidation or dissolution of the Company; or

                                       2
<PAGE>

                           (iv)     The sale of at least 80% of the assets of
the Company to an unrelated party, or completion of a transaction having a
similar effect; or

                           (v)      The individuals who on the date of this
Agreement constitute the Board thereafter cease to constitute at least a
majority thereof; provided, however, that any person becoming a member of the
Board subsequent to the date of this Agreement and whose election or nomination
was approved by a vote of at least two-thirds of the directors who then
comprised the Board immediately prior to such vote shall be considered a member
of the Board on the date of this Agreement.

         3.       Non-Transferable. Except as specifically authorized by the
Committee, the Participant may not transfer the Options except by will or the
laws of descent and distribution and the Options shall be exercisable during
the Participant's lifetime only by the Participant or, in the event of his
incapacity, his guardian or legal representative. Except as so authorized, no
purported assignment or transfer of the Options, or of the rights represented
thereby, whether voluntary or involuntary, by operation of law or otherwise
(except by will or the laws of descent and distribution), shall vest in the
assignee or transferee any interest or right herein whatsoever.

         4.       Termination of Employment.

                  (a)      Disability; Retirement. If, prior to the Expiration
Date, the Participant shall cease to be employed by the Company by reason of a
Disability or retirement from the Company pursuant to any retirement plan of
the Company, or the Participant's employment with the Company ceases for any
reason with the written consent of the Committee, then the Options shall remain
exercisable until the earlier of the Expiration Date or the date that is thirty
(30) days after the date of such cessation of employment, but only to the
extent the Options were vested and exercisable at the time of such cessation of
employment.

                  (b)      Without Cause. If the Company terminates the
Participant's employment without Cause, then upon such cessation of employment
all then unvested Options shall automatically vest and be fully exercisable and
all then unexercised Options shall be exercisable in accordance with the terms
of this Agreement until the earlier of the Expiration Date or the date that is
one (1) year after the date of such cessation of employment.

                  (c)      Voluntary; For Cause. If the Participant voluntarily
terminates employment with the Company for reasons other than Disability or
retirement pursuant to any retirement plan of the Company and without the
consent of the Committee or the Company terminates the Participant's employment
for Cause, then all of the Options, to the extent not exercised prior to such
termination, whether exercisable or not, shall lapse and be canceled
immediately upon such cessation of employment.

                  (d)      Death. If the Participant shall cease to be employed
by the Company prior to the Expiration Date by reason of death, or the
Participant shall die while entitled to exercise any of the Options pursuant to
Section 4(a) or 4(b), the executor or administrator of the estate of the
Participant or the person or persons to whom the Options shall have been
validly transferred by the executor or administrator pursuant to will or the
laws of descent and distribution shall have the right, until the earlier of the
Expiration Date or one (1) year after the date of death, to

                                       3
<PAGE>

exercise the Options, but only to the extent that the Participant was entitled
to exercise them on the date of death and subject to any other limitation
contained herein on the exercise of the Options in effect on the date of
exercise.

                  (e)      Whether employment has been or could have been
terminated for the purposes of this Agreement, and the reasons therefor, shall
be determined by the Committee, whose determination shall be final, binding and
conclusive.

                  (f)      Except as otherwise provided in this Section 4,
Options that have not yet vested at the time of termination of the
Participant's employment with the Company shall expire and no further vesting
shall occur with respect thereto. After the expiration of any exercise period
described in this Section 4, the Options and all of the Participant's rights
hereunder, to the extent not previously exercised, shall terminate.

         5.       Adjustments and Corporate Reorganizations. In accordance with
and subject to the applicable terms of the Plan, the Options shall be subject
to adjustment or substitution, as determined by the Committee, as to the
number, price or kind of Stock or other consideration subject to such Options
or as otherwise determined by the Committee to be equitable (i) in the event of
changes in the outstanding Stock or in the capital structure of the Company by
reason of stock dividends, stock splits, reverse stock splits,
recapitalizations, reorganizations, mergers, consolidations, combinations,
exchanges, or other relevant changes in capitalization occurring after the date
hereof or (ii) in the event of any change in applicable laws or any change in
circumstances which results in or would result in any substantial dilution or
enlargement of the rights granted to, or available for, the Participant. The
Company shall give the Participant written notice of an adjustment hereunder.
Notwithstanding anything herein to the contrary, in the event of any of the
following:

                  (a)      The Company is merged or consolidated with another
corporation or entity and, in connection therewith, consideration is received
by shareholders of the Company in a form other than stock or other equity
interests of the surviving entity;

                  (b)      All or substantially all of the assets of the
Company are acquired by another person;

                  (c)      The Company's reorganization or liquidation; or

                  (d)      The Company shall enter into a written agreement to
undergo an event described in clauses (a), (b) or (c) above,

then the Committee may, in its discretion and upon at least 10 days advance
notice to the affected persons, cancel any outstanding Options and pay to the
Participant, in cash, the value of such Options based upon the price per share
of Stock received or to be received by other shareholders of the Company in
such event and the per share exercise price of the Options.

         6.       Exercise; Payment for and Delivery of Common Stock. The
Options shall be exercised by delivering written notice to the Committee
stating the number of shares of Common Stock to be purchased, the person or
persons in whose name the shares of Common Stock are to

                                       4
<PAGE>

be registered and each such person's address and social security number. Such
notice shall not be effective unless accompanied by the full purchase price for
all shares to be purchased, and any applicable withholding (as described
below). The purchase price shall be payable in cash, in shares of Common Stock,
any combination of cash or shares of Common Stock or any other method
authorized by the Plan and consented to by the Committee; provided, however,
that the Participant may use Common Stock in payment of the exercise price only
if the shares so used are considered "mature" for purposes of generally
accepted accounting principles (i.e., (i) been held by the Participant free and
clear for at least six (6) months prior to the use thereof to pay part of an
Option exercise price, (ii) been purchased by the Participant in other than a
compensatory transaction, or (iii) meet any other requirements for "mature"
shares as may exist on the date of the use thereof to pay part of an Option
exercise price). In the event that all or part of the purchase price is paid in
shares of Common Stock, the shares used in payment shall be valued at their
Fair Market Value on the date of exercise of the Options. At the time of
exercise, the Participant shall pay to the Company, in cash, or by having the
Company withhold upon exercise of the Option a sufficient number of shares of
Common Stock otherwise deliverable to the Participant based on the Fair Market
Value of the Common Stock on the date of exercise, at the election of the
Participant, such minimum amount as the Company deems necessary to satisfy its
obligation to withhold Federal, state or local income or other taxes incurred
by reason of the exercise or the transfer of shares thereupon. Payment in
currency or by certified or cashier's check shall be considered payment in
cash.

         7.       Restrictive Covenants; Repurchase Rights.

                  (a)      By accepting the Options, the Participant represents
and agrees for himself and his transferees (whether by will or the laws of
descent and distribution) that:

                           (i)      For the period commencing on the date of
this Agreement and ending on the first one year anniversary of the termination
of the Participant's employment (such period is hereinafter referred to as the
"Restricted Period"), with respect to any geographic territories in which the
Participant engaged in business or had supervisory and/or management
responsibility during the Participant's employment with the Company, the
Participant shall not participate or engage, directly or indirectly, for
himself or herself or on behalf of or in conjunction with any person,
partnership, corporation or other entity, whether as an employee, agent,
officer, director, shareholder, partner, joint venturer, investor or otherwise
(other than a limited partner or stockholder of less than one percent of the
issued and outstanding limited partnership interests or stock of a publicly
held partnership or corporation whose gross assets exceed $1,000,000), in the
distribution, solicitation, promotion, manufacture, design, development, or
sale of any medical products or services competitive with products
manufactured, marketed, or sold by the Company or any of its subsidiaries or
any medical products or services intended to be manufactured, marketed, or sold
by the Company of the same general type or function.

                           (ii)     Except with the Company's prior written
approval or as may otherwise be required by law or legal process, the
Participant agrees not to disclose or use any material or information which is
confidential to the Company or its subsidiaries and not in the public domain or
generally known in the industry, whether tangible or intangible, made

                                       5
<PAGE>

available, disclosed or otherwise known to the Participant as a result of his
employment with the Company for so long as such information remains
confidential and not in the public domain.

                           (iii)    During the Restrictive Period, the
Participant shall not attempt to influence, persuade or induce, or assist any
other person in so persuading or inducing, any employee of the Company or its
subsidiaries to give up, or to not commence, employment or a business
relationship with the Company.

The parties intend the restrictions in this Paragraph 7(a) to be completely
severable and independent, and any invalidity or unenforceability of any one or
more of such restrictions shall not render invalid or unenforceable any one or
more restrictions.

                  (b)      In addition to all other legal and equitable
remedies available to it, the Company shall have the right, and not the
obligation, to purchase and acquire from the Participant any or all of the
shares of Common Stock previously acquired by the Participant upon exercise of
the Option (the "Repurchased Shares") if the Committee elects to take such
action, in its absolute discretion, on the basis of the Committee's
determination that the Participant has violated any of the covenants set forth
in this Agreement or if the Participant's employment is terminated or could
have been terminated for Cause. The Company may exercise the right granted to
it under this Section 7(b) by delivering written notice to the Participant
stating that the Company is exercising the repurchase right granted to it under
this Section 7(b). The delivery of such notice by the Company to the
Participant shall constitute a binding commitment of the Company to purchase
and acquire all of the Repurchased Shares. The total purchase price for the
Repurchased Shares shall be delivered to the Participant against delivery by
the Participant of certificates evidencing the Repurchased Shares no later than
30 days after the delivery of the election notice by the Company. The price per
share of the Repurchased Shares shall be the lesser of the Fair Market Value of
each of the Repurchased Shares on the date of the Company's delivery of its
written notice to the Participant or the exercise price of the Option.

                  (c)      In addition to all other legal and equitable
remedies available to it, the Company shall have the right, and not the
obligation, to cancel any or all of the Participant's Options if the Committee
elects to take such action, in its absolute discretion, on the basis of the
Committee's determination that the Participant has violated the covenants set
forth in this Agreement. The Company may exercise the right granted to it under
this Section 7(c) by delivering a written notice to the Participant stating
that the Company is exercising the cancellation right granted to it under this
Section 7(c).

                  (d)      Anything in this Section 7 to the contrary, the
Company shall not be obligated to purchase any Common Stock at any time to the
extent that the purchase would result in a violation of any law, statute, rule,
regulation, order, writ, injunction, decree or judgment promulgated or entered
by any Federal, state, local or foreign court or governmental authority
applicable to the Company or any of its property.

                                       6
<PAGE>

         8.       Rights as Stockholder.

                  (a)      The Participant or a transferee of the Options shall
have no rights as a stockholder with respect to any shares covered by the
Options until he shall have become the holder of record of such shares (and the
Company shall use its reasonable best efforts to cause the Participant promptly
to become the holder of record of such shares), and, except as provided in
Section 5 hereof, no adjustment shall be made for dividends or distributions or
other rights in respect of such shares for which the record date is prior to
the date upon which he shall become the holder of record thereof.

                  (b)      The Participant acknowledges and agrees that any
Common Stock acquired in respect of the Options granted under Section 2 shall
be "Shares" as such term is used in the Stockholders Agreement, dated as of
December 7, 1999, among the Company and certain "Investors" listed in Schedule
I thereto, and, as such, will be subject to certain restrictions, including
restrictions on resale and such other transfers. In the event of any conflict
or inconsistency between the terms and provisions of this Agreement and the
Stockholders Agreement, the Stockholders Agreement shall govern and control.

         9.       Company; Participant.

                  (a)      The term "Company" as used in this Agreement with
reference to employment or as otherwise indicated by the context shall include
the Company and its Related Entities.

                  (b)      Whenever the word "Participant" is used in any
provision of this Agreement under circumstances where the provision should
logically be construed to apply to the executors, the administrators, the legal
representatives, the person or persons to whom the Options may be transferred
by will or by the laws of descent and distribution or any other transferee to
whom the Options may be transferred with the consent of the Committee, the word
"Participant" shall be deemed to include such person or persons.

         10.      Requirements of Law.

                  (a)      By accepting the Options, the Participant represents
and agrees for himself and his transferees (whether by will or the laws of
descent and distribution) that, unless a registration statement under the
Securities Act is in effect as to the shares purchased upon any exercise of the
Options, (i) any and all shares so purchased shall be acquired for his personal
account and not with a view to or for sale in connection with any distribution,
and (ii) each notice of the exercise of any portion of this Option shall be
accompanied by a representation and warranty in writing, signed by the person
entitled to exercise the same, that the shares are being so acquired in good
faith for his personal account and not with a view to or for sale in connection
with any distribution.

                  (b)      No certificate or certificates for shares of Common
Stock may be purchased, issued or transferred if the exercise hereof or the
issuance or transfer of such shares shall constitute a violation by the Company
or the Participant of any (i) provision of any Federal, state or other
securities law, (ii) requirement of any securities exchange listing agreement

                                       7
<PAGE>

to which the Company may be a party, or (iii) other requirement of law or of
any regulatory body having jurisdiction over the Company. Any reasonable
determination in this connection by the Board, upon notice given to the
Participant, shall be final, binding and conclusive.

                  (c)      The certificates representing shares of Common Stock
acquired pursuant to the exercise of Options shall carry such appropriate
legend, and such written instructions shall be given to the Company's transfer
agent, as may be deemed necessary or advisable by counsel to the Company in
order to comply with the requirements of the Securities Act or any state
securities laws.

         11.      Notices. Any notice to be given to either party shall be in
writing and shall be given by hand delivery to such party or by registered or
certified mail, return receipt requested, postage prepaid, addressed to the
Company in care of its Secretary at its principal office, and to the
Participant at the address given beneath his signature hereto, or at such other
address as either party shall have furnished to the other in writing in
accordance herewith. Notice and communications shall be effective when actually
received by the addressee.

         12.      Binding Effect. This Agreement shall be binding upon the
heirs, executors, administrators, successors and permitted assigns of the
parties hereto.

         13.      The Plan. The terms and provisions of the Plan are
incorporated herein by reference and made a part hereof as though fully set
forth herein. In the event of any conflict or inconsistency between
discretionary terms and provisions of this Agreement, this Agreement shall
govern and control. In all other instances of conflicts or inconsistencies or
omissions, the terms and provisions of the Plan shall govern and control. All
capitalized terms not otherwise expressly defined in this Agreement shall have
the meaning ascribed to them in the Plan.

         14.      Governing Law. This Agreement shall be construed and
interpreted in accordance with the laws of the State of Tennessee, without
regard to the principles of conflicts of law thereof.

         15.      Entire Agreement. This Agreement, together with the Plan,
contains the entire agreement and understanding between the parties with
respect to the subject matter hereof and supersedes all prior agreements,
written or oral, with respect thereto. This Agreement, and this integration
clause, is not intended to, and does not, limit or alter in any manner, the
parties' obligations under any previous agreement concerning obligations to
maintain confidentiality or with respect to restrictive covenants, including,
but not limited to, any Nondisclosure Agreement, Confidentiality and Inventions
Agreement, Employment Agreement, Distributor Agreement, Sales Representative
Agreement, or any similar agreement between the parties, all of which
obligations shall remain in full force and effect.

                                       8
<PAGE>

         IN WITNESS WHEREOF, the Company has granted this Option on the date of
grant specified above. This instrument may be executed in any number of
counterparts, each of which shall be deemed to be an original, and such
counterparts together shall constitute one and the same instrument.

                                    WRIGHT MEDICAL GROUP, INC.

                                    By:
                                       ----------------------------------------
                                           Jason P. Hood
                                           Vice President, General Counsel, and
                                               Secretary

ACCEPTED:

----------------------------------
Participant

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00066-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00066-of-00352.parquet"}]]